Abstract:Immunoglobulin A vasculitis (IgAV; formerly Henoch Schonlein Purpura) is the most common form of childhood vasculitis. It can occur in any age and peaks around 4–6 years old. It demonstrates seasonal variation implicating a role for environmental triggers and geographical variation. The diagnosis is made clinically and 95% of patients will present with a rash, together with any from a triad of other systems—gastrointestinal, musculoskeletal, and renal. Most cases of IgAV in children have an excellent outcome. Treatment may be required during the acute phase for gastrointestinal involvement and renal involvement, termed IgAV nephritis (previously HSP nephritis), is the most serious long-term manifestation accounting for ~1–2% of all childhood end stage kidney disease (ESKD). It therefore requires a period of renal monitoring conducted for 6–12 months. Patients presenting with nephrotic and/or nephritic syndrome or whom develop significant persistent proteinuria should undergo a renal biopsy to evaluate the extent of renal inflammation and there are now international consensus guidelines that outline the indications for when to do this. At present there is no evidence to support the use of medications at the outset in all patients to prevent subsequent renal inflammation. Consensus management guidelines suggest using oral corticosteroids for milder disease, oral, or intravenous corticosteroids plus azathioprine or mycophenolate mofetil or intravenous cyclophosphamide for moderate disease and intravenous corticosteroids with cyclophosphamide for severe disease. Angiotensin system inhibitors act as adjunctive treatment for persisting proteinuria and frequently relapsing disease may necessitate the use of immunosuppressant agents. Renal outcomes in this disease have remained static over time and progress may be hindered due to many reasons, including the lack of reliable disease biomarkers and an absence of core outcome measures allowing for accurate comparison between studies. This review article summarizes the current evidence supporting the management of this condition highlighting recent findings and areas of unmet need. In order to improve the long term outcomes in this condition international research collaboration is urgently required.

Post‐streptococcal small‐vessel vasculitis in a 16‐month‐old with associated intussusception and hypertension: Henoch Schönlein purpura?

IgA Vasculitis:A Review on Diagnosis and Management

Atypical purpura location in a pediatric patient with Henoch-Schönlein purpura: A case report.

The Laboratory Differential Diagnosis of Henoch-Schonlein Purpura

Henoch-Schönlein Purpura: A Case Report and Review of Literature

Rare Superior Mesenteric Artery Syndrome in an Eight-Year-Old Girl With Henoch-Schönlein Purpura: A Case Report

Pneumatosis intestinalis associated with Henoch-Schönlein purpura

Early recognition and treatment of Henoch-Schönlein purpura in children

Effective treatment with intravenous immunoglobulin for Henoch–Schönlein purpura with refractory gastrointestinal symptoms in an adolescent: A CARE-compliant case report

Henoch–Schönlein purpura: Simultaneous occurrence in two siblings—Case reports

Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review

Henoch schonlein purpura--a 5-year review and proposed pathway

Invasive meningococcal disease presenting as Henoch-Schonlein purpura

necrotizing glomerulonephritis secondary to henoch schonleinpurpura and streptococcal infection with a successful response to cyclophosphamide treatment a case report

Pathogenesis of IgA Vasculitis: An Up-To-Date Review

Time of Onset and Risk Factors of Renal Involvement in Children with Henoch-Schönlein Purpura: Retrospective Study

Viral Infections May Be Associated with Henoch–Schönlein Purpura

Risk Factors for Renal Involvement in Childhood Henoch-Schonlein Purpura (IgA Vasculitis)

Childhood IgA Vasculitis (Henoch Schonlein Purpura)—Advances and Knowledge Gaps

[Clinical characteristics of Henoch-Schönlein purpura in children]

[Henoch-Schönlein purpura with late-onset necrotising glomerulonephritis--a case report]